In this study, we compared the ability of metformin or lovastatin to enhance the cytotoxicity of gefitinib in various LKB1 deficient cell lines including A549 (NSCLC) and HeLa and LKB1 expressing SCC25 and SCC9 cell lines. This evidence concerns the gene STK11 and non-small cell lung carcinoma.